227 related articles for article (PubMed ID: 35405726)
1. Cystic Lesions of the Pancreas: Is Apparent Diffusion Coefficient Value Useful at 3 T Magnetic Resonance Imaging?
Boraschi P; Scalise P; Casotti MT; Kauffmann EF; Boggi U; Donati F
J Comput Assist Tomogr; 2022 May-Jun 01; 46(3):363-370. PubMed ID: 35405726
[TBL] [Abstract][Full Text] [Related]
2. Role of volumetric multiparametric MRI in distinguishing between intraductal papillary mucinous neoplasms and serous cystadenoma.
Ghadimi M; Pandey P; Rezvani Habibabadi R; Motaghi M; Shaghaghi M; Khoshpouri P; Pandey A; Hazhirkarzar B; Ameli S; Ghasabeh MA; Baghdadi A; Kamel IR
Abdom Radiol (NY); 2021 Apr; 46(4):1629-1639. PubMed ID: 33033892
[TBL] [Abstract][Full Text] [Related]
3. Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Zhang L; Rao SX; Xu XF; Wang DS; Jin da Y; Zeng MS
Diagn Interv Radiol; 2016; 22(4):308-13. PubMed ID: 27283593
[TBL] [Abstract][Full Text] [Related]
4. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values.
Boraschi P; Donati F; Gigoni R; Salemi S; Bartolozzi C; Falaschi F
Magn Reson Imaging; 2010 Dec; 28(10):1447-55. PubMed ID: 20864287
[TBL] [Abstract][Full Text] [Related]
6. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts.
Pozzessere C; Castaños Gutiérrez SL; Corona-Villalobos CP; Righi L; Xu C; Lennon AM; Wolfgang CL; Hruban RH; Goggins M; Canto MI; Kamel IR
J Comput Assist Tomogr; 2016; 40(4):505-12. PubMed ID: 27023856
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging in characterization of cystic pancreatic lesions.
Sandrasegaran K; Akisik FM; Patel AA; Rydberg M; Cramer HM; Agaram NP; Schmidt CM
Clin Radiol; 2011 Sep; 66(9):808-14. PubMed ID: 21601184
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cystic ovarian lesions using apparent diffusion coefficient calculated from turboFLASH MR images.
Moteki T; Ishizaka H
Br J Radiol; 1998 Jun; 71(846):612-20. PubMed ID: 9849383
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results.
Mottola JC; Sahni VA; Erturk SM; Swanson R; Banks PA; Mortele KJ
Abdom Imaging; 2012 Feb; 37(1):110-7. PubMed ID: 21512724
[TBL] [Abstract][Full Text] [Related]
11. [MRI-cholangiopancreatography characteristics of cystic pancreatic tumors].
Dupas B; Le Borgne J
Ann Chir; 2000 Jul; 125(6):571-7. PubMed ID: 10986770
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cystic ovarian lesions using apparent diffusion coefficient calculated from reordered turboflash MR images.
Moteki T; Ishizaka H
Magn Reson Imaging; 1999 Sep; 17(7):955-63. PubMed ID: 10463644
[TBL] [Abstract][Full Text] [Related]
13. EUS in the evaluation of pancreatic cystic lesions.
Song MH; Lee SK; Kim MH; Lee HJ; Kim KP; Kim HJ; Lee SS; Seo DW; Min YI
Gastrointest Endosc; 2003 Jun; 57(7):891-6. PubMed ID: 12776038
[TBL] [Abstract][Full Text] [Related]
14. CYSTIC PANCREATIC LESIONS: IMAGING VERSUS ANATOMOPATHOLOGICAL FINDINGS-HOW TO IMPROVE DIAGNOSTIC ACCURACY?
Vieira RMF; Souza Junior AS; Kerche LE
Arq Bras Cir Dig; 2023; 36():e1735. PubMed ID: 37255104
[TBL] [Abstract][Full Text] [Related]
15. New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous cystadenoma and mucinous cystic tumor: a prospective study.
Schraibman V; Goldman SM; Ardengh JC; Goldenberg A; Lobo E; Linhares MM; Gonzales AM; Abdala N; Abud TG; Ajzen SA; Jackowsky A; Szejnfeld J
Pancreatology; 2011; 11(1):43-51. PubMed ID: 21412024
[TBL] [Abstract][Full Text] [Related]
16. Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging.
Irie H; Honda H; Kuroiwa T; Yoshimitsu K; Aibe H; Shinozaki K; Masuda K
Abdom Imaging; 2002; 27(1):82-7. PubMed ID: 11740615
[TBL] [Abstract][Full Text] [Related]
17. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
18. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.
O'Toole D; Palazzo L; Hammel P; Ben Yaghlene L; Couvelard A; Felce-Dachez M; Fabre M; Dancour A; Aubert A; Sauvanet A; Maire F; Lévy P; Ruszniewski P
Gastrointest Endosc; 2004 Jun; 59(7):823-9. PubMed ID: 15173795
[TBL] [Abstract][Full Text] [Related]
19. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
Munigala S; Javia SB; Agarwal B
Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
Kang KM; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
